A systematic review by Li Q et al. [23] confirmed that IL-17, as an effector molecule similar to IFN-γ, protects humans from M. tb after BCG vaccination and M. tb infection, and the current evidence does not support that IL-17 would be an inducer of tissue damage in TB. Here, IL17A is linked to tuberculosis.